Jane Street’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Buy
239,792
+97,899
+69% +$1.19M ﹤0.01% 4680
2026
Q1
$1.98M Sell
141,893
-87,171
-38% -$1.22M ﹤0.01% 5111
2025
Q4
$3.3M Buy
+229,064
New +$3.45M ﹤0.01% 3897
2025
Q2
Sell
-700,000
Closed -$14.6M 9694
2025
Q1
$14.6M Buy
700,000
+640,572
+1,078% +$12.1M ﹤0.01% 1566
2024
Q4
$1.1M Sell
59,428
-180,520
-75% -$3.47M ﹤0.01% 5201
2024
Q3
$4.7M Sell
239,948
-300,980
-56% -$5.99M ﹤0.01% 2962
2024
Q2
$10.6M Buy
540,928
+463,921
+602% +$8.8M ﹤0.01% 1986
2024
Q1
$1.39M Sell
77,007
-207,426
-73% -$3.76M ﹤0.01% 4796
2023
Q4
$4.82M Buy
+284,433
New +$5.65M ﹤0.01% 2904
2023
Q3
Sell
-37,645
Closed -$706K 8667
2023
Q2
$706K Buy
+37,645
New +$759K ﹤0.01% 5775
2022
Q4
Sell
-163,013
Closed -$3.31M 9180
2022
Q3
$3.31M Buy
+163,013
New +$3.25M ﹤0.01% 3295
2020
Q4
Sell
-10,002
Closed -$236K 7494
2020
Q3
$236K Buy
+10,002
New +$240K ﹤0.01% 6217
2019
Q4
Sell
-121,740
Closed -$2.88M 5073
2019
Q3
$2.88M Buy
121,740
+99,035
+436% +$2.3M ﹤0.01% 1451
2019
Q2
$498K Buy
+22,705
New +$495K ﹤0.01% 3580
2018
Q4
Sell
-23,531
Closed -$475K 4958
2018
Q3
$475K Sell
23,531
-11,363
-33% -$228K ﹤0.01% 3681
2018
Q2
$700K Sell
34,894
-7,243
-17% -$140K ﹤0.01% 3206
2018
Q1
$817K Buy
+42,137
New +$789K ﹤0.01% 2917
2017
Q4
Sell
-37,704
Closed -$725K 4575
2017
Q3
$725K Buy
37,704
+7,286
+24% +$146K ﹤0.01% 2654
2017
Q2
$609K Buy
30,418
+1,120
+4% +$22.6K ﹤0.01% 2764
2017
Q1
$579K Sell
29,298
-13,936
-32% -$270K ﹤0.01% 2705
2016
Q4
$852K Buy
43,234
+28,875
+201% +$583K ﹤0.01% 2252
2016
Q3
$302K Sell
14,359
-19,303
-57% -$421K ﹤0.01% 3302
2016
Q2
$783K Buy
+33,662
New +$739K ﹤0.01% 2273
2015
Q4
Sell
-14,828
Closed -$315K 4003
2015
Q3
$315K Sell
14,828
-6,609
-31% -$134K ﹤0.01% 2740
2015
Q2
$405K Buy
+21,437
New +$415K ﹤0.01% 2495

Other funds holding BTAL

Jane Street's BTAL Position: Q2 2026 in Review

Jane Street increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 69% in Q2 2026, buying an estimated $1.19M and bringing the position to 239,792 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #4680.

Jane Street first reported a position in BTAL in Q2 2015 and has held it in 25 quarters since. The position peaked at $14.6M in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Jane Street held 239,792 shares of AGF US Market Neutral Anti-Beta Fund worth $2.67M as of Q2 2026.
  • Jane Street bought 97,899 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $1.19M.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4680 holding.
  • Jane Street first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2015 and has held it in 25 quarters since.
  • Jane Street's AGF US Market Neutral Anti-Beta Fund position peaked at $14.6M in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.